Maze Therapeutics (MAZE) Return on Equity (2024 - 2026)

Maze Therapeutics has disclosed Return on Equity across 3 years of filings, most recently posting 0.0% for Q1 2026.

• Return on Equity for Q1 2026 came in at 0.0%, up 5.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.0% (up 5.0% YoY), and the FY2025 annual result was 0.06%, changed N/A from the prior year.
• Return on Equity came in at 0.0% for Q1 2026 at Maze Therapeutics, up from 0.0% in the prior quarter.
• In the past five years, Return on Equity ranged from a high of 0.0% in Q4 2024 to a low of 0.05% in Q1 2025.
• The 3-year median for Return on Equity is 0.0% (2025), against an average of 0.01%.
• Across the five-year window, Return on Equity changed 0 bps in 2025 and gained 5 bps in 2026, its largest moves.
• Maze Therapeutics' Return on Equity stood at 0.0% in 2024, then tumbled by 87 bps to 0.0% in 2025, then rose by 1 bps to 0.0% in 2026.
• The last three Return on Equity figures came in at 0.0% (Q1 2026), 0.0% (Q4 2025), and 0.0% (Q3 2025), per Business Quant data.